Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Oct;17(Suppl 1):S224-7.
doi: 10.4103/2230-8210.119579.

Familial vitamin D resistant rickets: End-organ resistance to 1,25-dihydroxyvitamin D

Sangita Choudhury  1 , K Felix Jebasingh, Salam Ranabir, Th Premchand Singh
Affiliations
Case Reports

Familial vitamin D resistant rickets: End-organ resistance to 1,25-dihydroxyvitamin D

Sangita Choudhury et al. Indian J Endocrinol Metab. 2013 Oct.

Abstract

Rickets is softening of bones due to defective mineralization of cartilage in the epiphyseal growth plate, leading to widening of ends of long bones, growth retardation, and skeletal deformities in children. The predominant cause is deficiency or impaired metabolism of vitamin D. The observation that some forms of rickets could not be cured by regular doses of vitamin D, led to the discovery of rare inherited abnormalities of vitamin D metabolism or vitamin D receptor. Vitamin D dependent rickets (VDDR) is of two types: Type I is due to defective renal tubular 25-hydroxyvitamin D 1-α hydroxylase and type II is due to end-organ resistance to active metabolite of vitamin D. Typical signs are observed from the first month of life. The patient with rickets described below had markedly increased serum alkaline phosphatase and 1,25-dihydroxyvitamin D. We attribute these abnormalities to impaired end-organ responsiveness to 1,25-dihydroxyvitamin D.

Keywords: 1,25-dihydroxyvitamin D; End-organ resistance; rickets; vitamin D; vitamin D dependent rickets.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Deformity in the upper limbs in both the cases
Figure 2
Figure 2
Deformity in the lower limbs in both the cases
Figure 3
Figure 3
Radiological changes including cupping, fraying, widening of metaphysis, and osteopenia in upper limbs in the patient
Figure 4
Figure 4
Radiological changes including cupping, fraying, widening of metaphysis, and osteopenia in upper limbs in the patient's sister
Figure 5
Figure 5
Radiological changes including cupping, fraying, widening of metaphysis, and osteopenia in lower limbs in the patient
Figure 6
Figure 6
Radiological changes including cupping, fraying, widening of metaphysis, and osteopenia in lower limbs in the patient's sister
See this image and copyright information in PMC

References

    1. Albright F, Butler AM, Bloomberg E. Rickets resistant to vitamin D therapy. AJDC. 1937;54:529–47.
    1. Sahay M, Sahay R. Rickets-vitamin D deficiency and dependency. Indian J Endocrinol Metab. 2012;16:164–76. - PMC - PubMed
    1. Fraher LJ, Karmali R, Hinde FR, Hendy GN, Jani H, Nicholson L, et al. Vitamin D-dependent rickets type II: Extreme end organ resistant to 1,25 dihydroxyvitamin D 3 in a patient without alopecia. Eur J Pediatr. 1986;145:389–95. - PubMed
    1. Litman NN, Ulstrom RA, Westin WW. Vitamin D resistant rickets. Calif Med. 1957;86:248–53. - PMC - PubMed
    1. Lips P. Vitamin D related disorders in primer on the metabolic bone disease and disorders of mineral metabolism. In: Rosen CJ, et al., editors. 7th ed. Washington: ASBMR; pp. 329–35.

Publication types